1-13 of 13
Jordan S Goldstein
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Baseline Prognostic Factors Do Not Predict End of Treatment Ctdna MRD Status and Have Limited Impact on MRD Prognostic Performance in DLBCL

Free
Jordan S Goldstein, Mark Roschewski, Won-Seog Kim, Sang Eun Yoon, Seok Jin Kim, Jason R. Westin, Ryan C Lynch, Stefan K. Alig, Sandra Close, Jacob Chabon, Davide Rossi, Wyndham H. Wilson, David Kurtz, Ash A. Alizadeh
Journal: Blood
Blood (2024) 144 (Supplement 1): 651.
https://doi.org/10.1182/blood-2024-211068
Published: 2024
Journal Articles

The Clinical Impact and Cost-Effectiveness of PET-Based and Ctdna-Based Evaluation at End-of-Therapy after Frontline Treatment of DLBCL

Free
Swetha Kambhampati, Jordan S Goldstein, Seth Buller, Mark Roschewski, Ash A. Alizadeh, Nikhil Thiruvengadam
Journal: Blood
Blood (2024) 144 (Supplement 1): 2276.
https://doi.org/10.1182/blood-2024-203873
Published: 2024
Journal Articles

Distinct Molecular Aberrations of Classic Hodgkin Lymphoma in Older Adults Identified By Comprehensive Genomic Profiling

Free
Cedric Rossi, Jan Boegeholz, Jordan S Goldstein, Shuyu Shi, Shengqin Su, Benoit Tessoulin, Stefan K. Alig, Andrea Garofalo, Mohammad Shahrokh Esfahani, Joseph G. Schroers-Martin, Chih Long Liu, Mari Olsen, Xiaoman Kang, Feng Tian, David Kurtz, Takeshi Sugio, Troy Noordenbos, Marc Andre, Luc-Matthieu Fornecker, Edith Julia, Alexandra Traverse-Glehen, Olivier Casasnovas, Michael S. Binkley, Maximilian Diehn, Herve Ghesquieres, Ash A. Alizadeh
Journal: Blood
Blood (2024) 144 (Supplement 1): 853.
https://doi.org/10.1182/blood-2024-201644
Published: 2024
Journal Articles

Ultrasensitive Circulating Tumor DNA MRD Status Predicts Treatment Failure & Complements PET/CT throughout Treatment for Early and Advanced Stage Classic Hodgkin Lymphoma

Free
Jan Boegeholz, Cedric Rossi, Jordan S Goldstein, Stefan K. Alig, Andrea Garofalo, Mohammad Shahrokh Esfahani, Joseph G. Schroers-Martin, Chih Long Liu, Mari Olsen, Xiaoman Kang, Feng Tian, David Kurtz, Marc Andre, Luc-Matthieu Fornecker, Olivier Casasnovas, Maximilian Diehn, Herve Ghesquieres, Ash A. Alizadeh
Journal: Blood
Blood (2024) 144 (Supplement 1): 565.
https://doi.org/10.1182/blood-2024-201877
Published: 2024
Journal Articles

Anatomic Genetic Heterogeneity Is Uncovered By Concurrent Cell-Free DNA and Tissue Profiling and Predicts Treatment Resistance in Diffuse Large B-Cell Lymphoma

Free
Jordan S Goldstein, Florian Scherer, Brian J. Sworder, Maximilian Diehn, David Kurtz, Ash A. Alizadeh
Journal: Blood
Blood (2024) 144 (Supplement 1): 4357.
https://doi.org/10.1182/blood-2024-209735
Published: 2024
Journal Articles

Evaluation of the Prognostic Utility of Bone Marrow Biopsy in Diffuse Large B-Cell Lymphoma: A SEER-Medicare Linked Database Analysis

Free
Danny Luan, MPH, Yiyuan Wu, MS, Jordan S. Goldstein, MDMSc, Sarah C. Rutherford, MD, John P. Leonard, MD, Peter Martin, FRCPC, MD MS
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-134950
Published: 2020
Journal Articles

Disparities in survival by insurance status in follicular lymphoma

Free
Clinical Trials & Observations
Jordan S. Goldstein, Loretta J. Nastoupil, Xuesong Han, Ahmedin Jemal, Elizabeth Ward, Christopher R. Flowers
Journal: Blood
Blood (2018) 132 (11): 1159–1166.
https://doi.org/10.1182/blood-2018-03-839035
Published: 2018
Includes: Supplemental data
Journal Articles

Insurance Status Impacts Survival in Burkitt Lymphoma

Free
Jordan S. Goldstein, BS, Jeffrey M. Switchenko, PhD MS, Madhusmita Behera, PhD, Christopher Flowers, MD, Jean L. Koff, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 916.
https://doi.org/10.1182/blood.V130.Suppl_1.916.916
Published: 2017
Journal Articles

Overall Survival Disparities in Metro/Urban/Rural Diffuse Large B-Cell Lymphoma (DLBCL) Patients

Free
Andrew J. Ritter, Jordan S. Goldstein, BS, Anh Thuy Phan, MPH, Christopher Flowers, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4159.
https://doi.org/10.1182/blood.V130.Suppl_1.4159.4159
Published: 2017
Journal Articles

A Multi-State Model for Follicular Lymphoma in Patients with Early Progression to Second Line Therapy

Free
Caglar Caglayan, MS, Hiromi Terawaki, MD, Turgay Ayer, PhD, Jordan S. Goldstein, BS, Ashish Rai, MBBS, MPH, Qiushi Chen, PhD, Christopher Flowers, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2187.
https://doi.org/10.1182/blood.V130.Suppl_1.2187.2187
Published: 2017
Journal Articles

A Multi-State Model for Senior Patients with Diffuse Large B Cell Lymphoma

Free
Caglar Caglayan, MS, Jordan S. Goldstein, BS, Ashish Rai, MBBS, MPH, Christopher Flowers, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1558.
https://doi.org/10.1182/blood.V130.Suppl_1.1558.1558
Published: 2017
Journal Articles

PET-Derived Tumor Metrics Predict DLBCL Response and Progression-Free Survival

Free
Prioty Islam, MD MSc, Jordan S. Goldstein, BS, Ila Sethi, MD, Daniel Lee, MD, Christopher Flowers, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4140.
https://doi.org/10.1182/blood.V130.Suppl_1.4140.4140
Published: 2017
Journal Articles

Utilizing Digital Pathology Informatics Algorithms for Diffuse Large B-Cell Lymphoma Subtyping

Free
Jordan S. Goldstein, BS, Sanghoon Lee, Jacob Jordan, David L. Jaye, MD, Christopher Flowers, MD, Lee Cooper, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4147.
https://doi.org/10.1182/blood.V130.Suppl_1.4147.4147
Published: 2017